The biggest korean Venture Capital, Korea Investment Partners (KIP), which made an investment in Univercells and Promethera Biosciences will be also present and would like to seek for more Belgian partners at the conference and Korea Exchange (KRX), the sole, securities exchange operator in South Korea will give you useful information and clear guidelines of the IPO market in Korea.
For decades Belgium has been a key country in the development of the global Pharma-Bio sector, while Korea has become a front runner in emerging industries. Successful partnerships with major Belgian companies have contributed to the creation of innovative and sustainable business in the Korean pharmaceutical sector.
Representatives from the Korean leading companies of fiance, accounting and legal sectors and Belgian pharmaceutical industry representatives will highlight the possibilities for growth and cooperation.
B2B Networking Program in the afternoon will be a good chance for the Belgian pharma-bio companies to gain more investment by favouring a new partnership with the Korean investor.